Results 251 to 260 of about 25,235,368 (365)
Correction: Wu et al. 3D-Printed Multi-Stimulus-Responsive Hydrogels: Fabrication and Characterization. <i>Micromachines</i> 2025, <i>16</i>, 788. [PDF]
Wu J, Ma Z, Tang Q, Yang R.
europepmc +1 more source
Therapeutic strategies for MMAE‐resistant bladder cancer through DPP4 inhibition
We established monomethyl auristatin E (MMAE)‐resistant bladder cancer (BC) cell lines by exposure to progressively increasing concentrations of MMAE in vitro. RNA sequencing showed DPP4 expression was increased in MMAE‐resistant BC cells. Both si‐DPP4 and the DPP4 inhibitor sitagliptin suppressed the viability of MMAE‐resistant BC cells.
Gang Li +10 more
wiley +1 more source
Correction: Urban environments' impacts on aging in post-industrial cities: reviewing the pathways to healthy aging. [PDF]
Zhao H, Spada M, Bortone I.
europepmc +1 more source
Nano‐Scale Interface Engineering of Sulfur Cathode to Enable High‐Performance All‐Solid‐State Li–S Batteries [PDF]
Haoyue Zhong +7 more
openalex +1 more source
Nanosecond infrared laser (NIRL) low‐volume sampling combined with shotgun lipidomics uncovers distinct lipidome alterations in oropharyngeal squamous cell carcinoma (OPSCC) of the palatine tonsil. Several lipid species consistently differentiate tumor from healthy tissue, highlighting their potential as diagnostic markers.
Leonard Kerkhoff +11 more
wiley +1 more source
Aging-Dependent Repair Performance and Interfacial Durability of New-Aged Waterproof Membrane Systems. [PDF]
Zhang C +5 more
europepmc +1 more source
Requirements are All You Need: The Final Frontier for End-User Software Engineering [PDF]
D.G. Robinson +4 more
openalex +1 more source
We show that the majority of the 18 analyzed recurrent cancer‐associated ERBB4 mutations are transforming. The most potent mutations are activating, co‐operate with other ERBB receptors, and are sensitive to pan‐ERBB inhibitors. Activating ERBB4 mutations also promote therapy resistance in EGFR‐mutant lung cancer.
Veera K. Ojala +15 more
wiley +1 more source

